Medway Community Healthcare Medway NHS Trust Foundation Trust
Medway Clinical Commissioning Group Swale Clinical Commissioning Group
Online Formulary

5.5.1 COVID-19

 
Nirmatrelvir plus Ritonavir,
Sotrovimab, 
Tocilizumab

These High-Cost Drugs has been approved for the following indications: - for treatment of COVID-19 as per NICE Guidance

 

NOT recommended by NICE.
(Casirivimab plus imdevimab (Ronapreve, Roche Products) is NOT recommended by NICE.)
For more information and NICE Guidance Click Here Casirivimab plus imdevimab, nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19 NICE Guidance TA878           
  • First Line Choice
  • On Formulary
  • Specialist Initiation Only
  • Hospital Only
  • KMPT Initiation Only
  •